Why the study?
Does intravenous propranolol alter hemodynamic performance in patients with complete heart block and implanted pacemakers at a constant ventricular rate?
Does intravenous propranolol alter hemodynamic performance in patients with complete heart block and implanted pacemakers at a constant ventricular rate?
Answers are grounded in this paper and cite their sources.
Intravenous propranolol reduces cardiac performance in patients with a fixed ventricular rate solely through its negative inotropic effect on the ventricular myocardium.
The hemodynamic effect of 5 mg propranolol intravenously was studied during permanent endocardial pacing in nine patients with complete atrioventricular heart block. The heart rate was constant at a preset pacemaker frequency. After the injection of propranolol the cardiac output was reduced in all patients and a fall in maximal arterial dp/dt was found. Atrial retardation occurred in all patients. The atrial contractility, as judged from the maximal atrial systolic pressure, was not reduced. It is concluded that the reduction of cardiac performance after propranolol in patients with constant ventricular rate is a result only of the negative inotropic effect on the ventricular myocardium.
No takes yet. Share an insight, caveat, or question.
Lund‐Larsen et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: